Last week, Quanergy's valuation surpassed $2 billion after the company raised an undisclosed amount of funding in its Series C round.
Shape Security raised $26 million in it Series E round at a $496 million valuation.
23andMe became the first company to obtain FDA clearance for its test that reports how a person’s genetics affect their reaction to certain drugs.
Carbon hired Elisa de Martel as its new CFO. She previously was the Manufacturing Finance Director at Apple, finance manager at Citroen UK and a supervisor at PricewaterhouseCoopers.
The news articles and links presented below are available for your reference.
"23andMe Can Now Tell You How You May Respond to Some Drugs. But Experts Are Wary"
"Carbon Announces Updates to Board of Directors and Appoints New CFO"
"Quanergy Completes Series C Financing With a Valuation Surpassing $2 Billion"
"Anti-fraud Startup Shape Security Raises $26M in Series E Round to Drive Global Expansion"